Related Experiment Video

Updated: Sep 30, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

[Appropriateness of lipid-lowering treatment and cardiovascular risk in patients with hypercholesterolemia]

X M Segade Buceta1, O Dosil Díaz

  • 1Area de Atención Primaria, Santiago de Compostela, La Coruna, Spain.

Gaceta Sanitaria
|July 11, 2002
PubMed

Insights

Over half of hypercholesterolemia patients received inappropriate lipid-lowering treatment. However, their overall cardiovascular risk is currently satisfactory, indicating a need for improved treatment guidelines.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Context:

  • Hypercholesterolemia is a significant risk factor for cardiovascular disease.
  • Assessing the appropriateness of lipid-lowering treatment is crucial for effective patient management.
  • Understanding the clinical and epidemiological profile of hypercholesterolemia patients informs public health strategies.

Purpose:

  • To evaluate the appropriateness of prescribed lipid-lowering therapies in hypercholesterolemia patients.
  • To identify the clinical and epidemiological characteristics of individuals diagnosed with hypercholesterolemia.
  • To assess cardiovascular risk using established risk stratification tools.

Summary:

  • A study of 724 hypercholesterolemia patients in urban health centers revealed that 44.2% of primary prevention patients received appropriate lipid-lowering treatment.
  • A significant proportion of patients in primary prevention (8.9%) exhibited high absolute cardiovascular risk (>/= 20% over 10 years).
  • The study utilized retrospective and cross-sectional designs, employing Sheffield and Framingham risk tables for cardiovascular risk assessment.

Impact:

  • Findings suggest a substantial gap in the appropriate prescription of lipid-lowering medications, potentially leading to suboptimal cardiovascular risk reduction.
  • Despite undertreatment in some cases, the overall current cardiovascular risk among the studied hypercholesterolemia patients was deemed satisfactory.
  • The study highlights the need for refining clinical guidelines and improving adherence to evidence-based treatment protocols for hypercholesterolemia management.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...